Kimberly Sciarretta: No relevant financial relationship(s) to disclose.
This session will consist of a discussion of the potential opportunity for host-directed therapeutics (HDTs) for treating infectious diseases and impacting critical care medicine. Opportunities and challenges related to the development and repurposing of HDTs will be explored.
Congress features sessions on a record-breaking number of new journal articles, guidelines, and research from SCCM and other leading medical journals. Find details here.
Learning Objectives:
Raise awareness of the potential opportunity for clinical development of host-directed therapeutics (HDTs)
Illuminate the strategic value of HDTs in pandemic preparedness
Elaborate on potential opportunities to repurpose therapeutics
Explore the clinical evidence needed to support further development and use of repurposed therapeutics
